Wason

Developing a composite outcome measure for frailty prevention trials - Rationale, derivation and sample size comparison with other candidate measures

*BMC Geriatrics* 2020; 20:113

Simple MRI score aids prediction of dementia in cerebral small vessel disease

*Neurology* 2020; 94(12):e1294-e1302

A web application for the design of multi-arm clinical trials

*BMC Cancer* 2020; 20:80

Imaging breast cancer using hyperpolarized carbon-13 MRI

*Proceedings of the National Academy of Sciences of the United States of America* 2020; 117(4):2092-2098

Sample size estimation using a latent variable model for mixed outcome co-primary, multiple primary and composite endpoints

*arXiv* 2019; arXiv:1912.05258

Overestimated treatment effects in randomised phase II trials: What's up doctor?

*European Journal of Cancer* 2019; 123:116-127

Two-stage adaptive designs for three-treatment bioequivalence studies

*Statistics in Biopharmaceutical Research* 2019; 11(4):360-374

Bayesian design and analysis of external pilot trials for complex interventions

*arXiv* 2019; arXiv:1908.05955

To add or not to add a new treatment arm to a multiarm study: A decision-theoretic framework

*Statistics in Medicine* 2019; 38(18):3305-3321

The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: Findings from the EpAID study

*Journal of Intellectual Disability Research* 2019; 63(12):1391-1400